Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Northwestern University
Robert H. Lurie Cancer Center
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Northwestern University
ClinicalTrials.gov Identifier:
First received: October 4, 2011
Last updated: August 24, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2018
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)